San Diego- and China-based BioDuro, which merged with San Diego’s Formex late last year, announced at BIO this week its formal acquisition of Formex to form…

Rockville, MD’s ABL has inked its second candidate manufacturing partnership in as many weeks, signing on with Regenxbio to produce the biotech’s lead adeno-…

Fujifilm Diosynth Biotechnologies U.S.A. has opened up a new biomanufacturing site in America’s CRO heartland as the company looks to boost its biologics…

Charles River Laboratories International has dotted all the i's and crossed all the t's on its $585 million acquisition of WIL Research.

Contract drugmaker Recipharm is promising to spend $45 million (€40 million) over the next three years to improve drug traceability in an effort to…

Onyx Scientific is set to increase the size of its U.K.-based site by more than 30% as it enjoys the spoils of a lucrative 2015.

Contract drug developer AMRI bolstered its client roster with three new agreements making use of its R&D, manufacturing and marketing divisions.

Chinese contract drug developer ShangPharma is planning to invest $60 million to build a biologics research and manufacturing outpost near its home base in…

Covance, now a division of LabCorp, is planning to build a second manufacturing-enabled pharmacy adjacent to one of its clinical research sites, allowing the…

Manufacturing